Suppr超能文献

APACHE II 评分优于 SOFA、CTP 和 MELD,可预测慢加急性肝衰竭(ACLF)患者的短期死亡率。

APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF).

机构信息

Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

J Dig Dis. 2013 Sep;14(9):484-90. doi: 10.1111/1751-2980.12074.

Abstract

OBJECTIVE

The aim of the study was to assess the performance of various prognostic scores including the acute physiology and chronic health evaluation (APACHE II), sequential organ failure assessment (SOFA), Child-Turcotte-Pugh (CTP) and model for end-stage liver disease (MELD) scores in predicting short-term mortality in patients with acute-on-chronic liver failure (ACLF).

METHODS

Altogether 100 consecutive patients with ACLF were evaluated prospectively. The diagnosis of ACLF was based on the Asian-Pacific Association for the Study of the Liver criteria except for the inclusion of non-hepatic insults as acute events. Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy for predicting short-term mortality was calculated for APACHE II, SOFA, CTP and MELD in all patients and Maddrey's discriminant function (DF) and Glasgow alcoholic hepatitis scores (GAHS) for patients with alcoholic hepatitis only.

RESULTS

Most patients had alcohol-related cirrhosis and alcoholic hepatitis as acute insults for ACLF. A total of 53 patients either died or left hospital in very sick status and were confirmed to have died the same day after leaving hospital. Overall, the area under the receiver operating characteristic curve of APACHE II was higher than those of MELD, SOFA and CTP scores for predicting short-term mortality. Even for patients with alcoholic hepatitis, APACHE II performed better than DF and GAHS.

CONCLUSIONS

Short-term mortality is high in patients with ACLF. APACHE II scoring system is superior to other prognostic scores in predicting its short-term mortality.

摘要

目的

本研究旨在评估各种预后评分系统在预测慢加急性肝衰竭(ACLF)患者短期死亡率方面的表现,包括急性生理学和慢性健康评估(APACHE II)评分、序贯器官衰竭评估(SOFA)评分、Child-Turcotte-Pugh(CTP)评分和终末期肝病模型(MELD)评分。

方法

前瞻性评估了 100 例连续的 ACLF 患者。ACLF 的诊断基于亚太肝脏研究协会标准,但将非肝脏损伤纳入急性事件。计算了 APACHE II、SOFA、CTP 和 MELD 评分在所有患者中预测短期死亡率的敏感性、特异性、阳性和阴性预测值及诊断准确性,并计算了 Maddrey 判别函数(DF)和格拉斯哥酒精性肝炎评分(GAHS)在仅患有酒精性肝炎的患者中的预测准确性。

结果

大多数患者的 ACLF 急性诱因与酒精相关的肝硬化和酒精性肝炎有关。共有 53 例患者在非常病重的情况下死亡或出院,出院后当天被证实死亡。总体而言,APACHE II 预测短期死亡率的受试者工作特征曲线下面积高于 MELD、SOFA 和 CTP 评分。即使是在患有酒精性肝炎的患者中,APACHE II 也优于 DF 和 GAHS。

结论

ACLF 患者的短期死亡率较高。APACHE II 评分系统在预测短期死亡率方面优于其他预后评分系统。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验